Management of the multiple symptoms of irritable bowel syndrome

详细信息    查看全文

• 作者：Prof Magnus Simré ; n ; MD^a ; ^b ; ^{magnus.simren@medicine.gu.se} ; Hans Tö ; rnblom ; MD^a ; Prof Olafur S Palsson ; PsyD^b ; Prof William E Whitehead ; PhD^b
• 刊名：The Lancet Gastroenterology & Hepatology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：2
• 期：2
• 页码：112-122
• 全文大小：293 K
• 卷排序：2

文摘

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. A stepwise management approach is advocated for patients with IBS. For a substantial proportion of patients with mild symptoms, general management principles, including making a confident diagnosis and offering explanation, reassurance, and dietary and lifestyle advice, are sufficient. However, many patients continue to have moderate-to-severe symptoms and are not satisfied solely with this approach. In these patients, use of pharmacotherapy on the basis of the predominant symptom (constipation, diarrhoea, pain, or bloating) or combination of symptoms is the next step. For patients with symptoms that are refractory to these initial treatment options and those who have comorbid conditions or psychological symptoms, a combination of therapies should be used, and the use of psychotropic drugs and psychological treatment alternatives is often effective. Finally, the key to successful treatment of patients with IBS is a good physician–patient relationship and use of person-centred care principles.